GATA6 and cancer: Consistent with observations from human snATAC-seq data analysis, we found fewer GATA6+ and GATA6high PDAC cancer cells in all liver metastases compared with in their matched primary pancreatic tumours (Fig. 4b,c; paired t-test, P = 0.066 and P = 0.057, respectively).